Showing results (511-520 of 551) with videos related to

Sort By:
Pageof 56
Neurology|June 10, 2016
A low-cost, tablet-based option for prehospital neurologic assessment: The iTREAT StudySherita N Chapman Smith, Prasanthi Govindarajan, Matthew M Padrick, et al.
Cancer Causes & Control : CCC|June 14, 2011
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control studySong Yao, Cathee Till, Alan R Kristal, et al.
Urology|March 4, 2015
Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade diseaseAshraful Hoque, Song Yao, Cathee Till, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancerBenjamin J Moeller, Vishal Rana, Blake A Cannon, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2010
Prospective imaging assessment of mortality risk after head-and-neck radiotherapyBenjamin J Moeller, Vishal Rana, Blake A Cannon, et al.
Journal of the National Cancer Institute|April 20, 2001
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancerS M Lippman, J J Lee, D D Karp, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 8, 2026
Liquid Biopsy Differentiation of Pancreatic Cancer From Non-Cancerous Pancreatic Disease Using Dielectrophoresis-Recovered Nanoparticles Carrying Cell-Free DNA and Protein BiomarkersAnna Malakian, Augusta Modestino, Jesus Bueno, et al.
Nature Communications|October 3, 2020
Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategyShumei Kato, Ki Hwan Kim, Hyo Jeong Lim, et al.
Nature Communications|July 10, 2018
Assembly and activation of the Hippo signalome by FAT1 tumor suppressorDaniel Martin, Maria S Degese, Lynn Vitale-Cross, et al.
Cancer|January 4, 2023
Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohortWilliam N William, Jianjun Zhang, Xin Zhao, et al.
Pageof 56